Abstract
Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015
Summary
GlobalData’s medical device report: “Brazil Diabetes Care Devices
Market Analysis and Forecasts to 2015” report provides key data,
information and analysis on the Brazil diabetes care devices market. The
report provides market landscape, competitive landscape and market trends
information on two market categories – glucose monitoring and insulin
delivery. The report provides comprehensive information on the key trends
affecting these categories, and key analytical insight on the market dynamics.
The report also reviews the competitive landscape in terms of mergers and
acquisitions, pipeline products and technology offerings.
Scope
- Forecasts & Analysis of the Brazil diabetes care devices market to 2015.
- Market segmentation by glucose monitoring and insulin delivery. Glucose
monitoring further segmented into blood glucose meters and blood glucose test
strips. Insulin delivery further segmented into insulin pens, insulin pumps,
insulin syringes and traditional insulin pump accessories. - Market
Analysis from 2001 to 2008, including new updated 2008 data. - Analysis of
the leading companies and competitive landscape including 2008 company market
share analysis. - Analysis of key diabetes care pipeline products, new
technologies and clinical trials. - Insight into the key mergers and
acquisitions (M&As), partnerships, venture capital and private equity
investments. - Qualitative analysis of market drivers, market limiters
regulatory issues and future outlook.
Reasons to buy
- Understand what the new growth opportunities are within the Brazil diabetes
care devices market. - Develop a clear knowledge & understanding of the
Brazil diabetes care devices competitor landscape and how this will change to
2015. - Identify acquisition opportunities across the Brazil diabetes care
devices market. - Identify key winners and losers and who is best
positioned to take advantage of the emerging market opportunities. -
Exploit in-licensing and out-licensing opportunities by identifying products,
most likely to ensure a robust return.
Keywords
brazil health structure, diabetes market, glucose monitoring, insulin
delivery, pens, pumps, meters, strips, distribution, average price, value,
competitive analysis, company share, market share, average price, pipeline
products, drivers, restraints, volume, F. Hoffmann-La Roche Ltd., LifeScan,
Inc., Abbott Laboratories, Bayer HealthCare AG, Becton, Dickinson and Company,
Medtronic, Inc., Eli Lilly and Company, Novo Nordisk A/S, Terumo Corporation,
Animas Corporation, Sanofi-Aventis, Apex Biotechnology Corp., Smiths
Medical.
|